HIGHLIGHTS
- who: Hendrik Bergsma from the Department of Nuclear Medicine, Erasmus Medical Center, ‘s-Gravendijkwal, CE Rotterdam, The Netherlands have published the Article: Nephrotoxicity after PRRT with 177Lu-DOTA-octreotate, in the Journal: (JOURNAL)
- what: A stronger correlation was observed with the decrease in CLR when applying this model, compared with using absorbed renal dose alone. The study showed that the maximum radiation dose to the kidney adopted from EBRT and PRRT with 90Y-labelled analogues does not seem to apply to PRRT with 177LuOctreotate.
- how: The results are in line with those of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.